Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Olanzapine (N05Ah03), Without Solid Oral Dosage Forms As Part Of A So-Called Open-House Model.